The Sixth People's Hospital of Zhengzhou, Zhengzhou, 450000, China.
The Sixth People's Hospital of Zhengzhou, Zhengzhou, 450000, China.
Microb Pathog. 2022 Aug;169:105633. doi: 10.1016/j.micpath.2022.105633. Epub 2022 Jun 11.
Norovirus (NoV) infection is a leading cause of non-bacterial gastroenteritis worldwide and there are currently no effective therapeutics available to target the virus. The norovirus major capsid protein VP1 is a potential candidate for the development of vaccines due to the similar morphology and immunogenicity of its assembled virus-like particles (VLPs) compared to native virions. In this study, we explored the effects of N- and C-terminal sequence additions to the VP1 of a GII.4 NoV during its assembly into VLPs. A series of sequences of different lengths derived from the minor capsid protein VP2 of the GII.4 NoV were added to the N- and C-terminus of VP1. The fusion proteins were expressed using a recombinant baculovirus expression system and the assembly of the expressed fusion proteins was subsequently observed under electron microscopy (EM). Our results indicated that all constructed fusion proteins were successfully expressed with different degrees of enzyme cleavage at the N-terminus. Electron microscopy revealed the successful assembly of VLPs of different sizes for all fusion proteins. An in vitro binding assay for VLP-histo-blood group antigens (HBGAs) indicated that all fusion proteins exhibited similar binding patterns compared with their wild-type VP1. Our results demonstrate that (Xi et al., 1990) [1] NoV VP1 can tolerate foreign sequences at its N- or C-terminus without affecting its ability to assemble into VLPs, and (Jiang et al., 1992) [2] that the cleavage pattern and effects of foreign sequences on the sizes of assembled VLPs observed in this study might represent important experimental data that can be used to elucidate VP1 self-assembly.
诺如病毒(NoV)感染是全球非细菌性胃肠炎的主要原因,目前尚无针对该病毒的有效治疗方法。诺如病毒主要衣壳蛋白 VP1 是疫苗开发的潜在候选物,因为其组装的病毒样颗粒(VLPs)与天然病毒粒子相比具有相似的形态和免疫原性。在这项研究中,我们探讨了在将 GII.4 NoV 的 VP1 组装成 VLPs 时,VP1 的 N 端和 C 端序列添加对其的影响。从 GII.4 NoV 的次要衣壳蛋白 VP2 衍生的一系列不同长度的序列被添加到 VP1 的 N 端和 C 端。融合蛋白使用重组杆状病毒表达系统表达,并在电子显微镜(EM)下观察表达融合蛋白的组装情况。我们的结果表明,所有构建的融合蛋白都成功表达,并且在 N 端都有不同程度的酶切。电子显微镜显示,所有融合蛋白都成功组装成不同大小的 VLPs。体外 VLPs-组织血型抗原(HBGAs)结合试验表明,与野生型 VP1 相比,所有融合蛋白均表现出相似的结合模式。我们的结果表明,(Xi 等人,1990)[1]NoV VP1 可以在其 N 端或 C 端容忍外源序列,而不影响其组装成 VLPs 的能力,并且(Jiang 等人,1992)[2]本研究中观察到的外源序列对组装 VLPs 大小的切割模式和影响可能代表可用于阐明 VP1 自组装的重要实验数据。